Schalken JA - Search Results

1

Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinoma.

Shimazui T, Oosterwijk E, Akaza H, Bringuier P, Ruijter E, van Berkel H, Wakka JO, van Bokhoven A, Debruyne FM, Schalken JA. Shimazui T, et al. Among authors: schalken ja. Clin Cancer Res. 1998 Oct;4(10):2419-24. Clin Cancer Res. 1998. PMID: 9796973

2

Karyometry of bladder washings for the follow up of patients with transitional cell carcinoma of the bladder.

van der Poel HG, Oosterhof GO, Schaafsma HE, Wiersma-van Tilburg A, Debruyne FM, Schalken JA. van der Poel HG, et al. Among authors: schalken ja. Prog Clin Biol Res. 1992;378:9-18. Prog Clin Biol Res. 1992. PMID: 1301590 No abstract available.

3

Increased expression of retroviral sequences in progressionally advanced rat prostatic tumors.

Bussemakers MJ, van Bokhoven A, van Groningen JJ, Debruyne FM, Schalken JA. Bussemakers MJ, et al. Among authors: schalken ja. Biochem Biophys Res Commun. 1992 Jan 15;182(1):318-24. doi: 10.1016/s0006-291x(05)80147-0. Biochem Biophys Res Commun. 1992. PMID: 1370615

4

Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer.

Verhagen AP, Ramaekers FC, Aalders TW, Schaafsma HE, Debruyne FM, Schalken JA. Verhagen AP, et al. Among authors: schalken ja. Cancer Res. 1992 Nov 15;52(22):6182-7. Cancer Res. 1992. PMID: 1384957

5

Identification of new prostate cancer progression markers by differential hybridization analysis.

Schalken JA, Debruyne FM. Schalken JA, et al. Eur Urol. 1992;21 Suppl 1:60-5. doi: 10.1159/000474893. Eur Urol. 1992. PMID: 1425840 Review.

6

Karyometry in recurrent superficial transitional cell tumors of the bladder.

van der Poel HG, van Caubergh RD, Boon ME, Debruyne FM, Schalken JA. van der Poel HG, et al. Among authors: schalken ja. Urol Res. 1992;20(5):375-81. doi: 10.1007/BF00922753. Urol Res. 1992. PMID: 1455571

7

Critical review of the models to study the biologic progression of bladder cancer.

Schalken JA, van Moorselaar RJ, Bringuier PP, Debruyne FM. Schalken JA, et al. Semin Surg Oncol. 1992 Sep-Oct;8(5):274-8. doi: 10.1002/ssu.2980080505. Semin Surg Oncol. 1992. PMID: 1462097 Review.

8

Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.

Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HF, Schaafsma HE, Debruyne FM, Isaacs WB. Umbas R, et al. Among authors: schalken ja. Cancer Res. 1992 Sep 15;52(18):5104-9. Cancer Res. 1992. PMID: 1516067

9

Differential expression of vimentin in rat prostatic tumors.

Bussemakers MJ, Verhaegh GW, van Bokhoven A, Debruyne FM, Schalken JA. Bussemakers MJ, et al. Among authors: schalken ja. Biochem Biophys Res Commun. 1992 Feb 14;182(3):1254-9. doi: 10.1016/0006-291x(92)91866-o. Biochem Biophys Res Commun. 1992. PMID: 1540169

10

Decreased expression of E-cadherin in the progression of rat prostatic cancer.

Bussemakers MJ, van Moorselaar RJ, Giroldi LA, Ichikawa T, Isaacs JT, Takeichi M, Debruyne FM, Schalken JA. Bussemakers MJ, et al. Among authors: schalken ja. Cancer Res. 1992 May 15;52(10):2916-22. Cancer Res. 1992. PMID: 1581909

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters